Zimmer Biomet: Robotically assisted knee replacement
Zimmer Biomet (NYSE:ZBH) is showing off its Rosa robotically-assisted total knee replacement surgery platform, cleared in January by FDA, and previewing some future innovations at AAOS. The newly cleared Rosa system includes 2D x-ray and 3D pre-operative planning tools and real-time intraoperative data on soft tissue and bone anatomy, allowing surgeons to conduct a “virtual knee replacement” with predictive outcomes
of balance and implant placement before performing any cuts.
In addition to helping surgeons improve bone cut accuracy and range of motion gap analysis, the Warsaw, Ind.–based company said that the Rosa system gives them the ability to analyze that data and link to post-operative long term outcomes.